Nobel Committee Honors Pioneers of Optogenetics for Light-Controlled Brain Research
The Nobel Assembly at Karolinska Institutet awarded the 2026 Physiology or Medicine prize to Karl Deisseroth, Peter Hegemann and Georg Nagel for their work on light-gated ion channels and the development of optogenetics.
On 5 October, the Nobel Assembly at Karolinska Institutet announced that Karl Deisseroth, Peter Hegemann and Georg Nagel will receive the 2026 Nobel Prize in Physiology or Medicine for their discoveries of light-gated ion channels and the creation of optogenetics. The method, which originated from studies of the green alga Chlamydomonas reinhardtii, allows researchers to activate or silence individual neurons with millisecond precision using light.
Deisseroth’s team demonstrated that delivering the channelrhodopsin-2 gene to mouse neurons via a virus enabled precise control of brain circuits, a breakthrough published in Nature Neuroscience. Over the following years, the toolkit expanded to include inhibitory proteins, multiple wavelengths, and faster variants, permitting detailed mapping of behaviors to specific neuronal populations. Clinical translation has begun, highlighted by a 2021 case where a blind patient regained limited vision through retinal optogenetic therapy, and ongoing work on optical cochlear implants. While still primarily a research instrument, optogenetics promises new avenues for treating neurological disorders and understanding brain function.
Why it matters
The award spotlights a technology that lets scientists control brain cells with light, opening new paths for neuroscience research and potential therapies.
In this story
